Rgenta Competitors and Similar CompaniesClear all
Rgenta's competitors and similar companies include Agenus, BeyondSpring, ABL Bio and NiKang Therapeutics.
 Rgenta Rgenta Therapeutics is a company developing RNA-targeting medicines focused on oncology and neurological disorders. |  Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer. |  BeyondSpring BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies. |  ABL Bio ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease. |  NiKang Therapeutics NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines. | |
Founding Date | Founding Date 2020 | Founding Date 1994 | Founding Date 2010 | Founding Date 2016 | Founding Date 2017 |
Type | Type Private | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Woburn, US HQ | Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US | Locations Florham Park, US HQ | Locations HQ | Locations Wilmington, US HQ |
Employees | Employees 313% decrease | Employees 38927% decrease | Employees 6712% decrease | Employees 55 | Employees 452% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 105.1 m | Valuation ($) 82.6 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $156.3m (FY, 2023) | Revenue (est.) $1.4m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income N/A | Net income ($257.4m) (FY, 2023) | Net income ($36.3m) (FY, 2022) | Net income N/A | Net income N/A |
Funding | |||||
Latest funding round | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 65m (over 6 years ago) | Latest funding round $ 200m (over 3 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 171.1m | Total funding raised $ 36.1m | Total funding raised $ 90.8m | Total funding raised $ 200m |
For sources of this data, please see the company profile
View Company Profiles
Agenus
HQ
Lexington, US
Employees
389↓ 27% decrease
Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
View companyBeyondSpring
HQ
Florham Park, US
Employees
67↓ 12% decrease
BeyondSpring (also known as Spring Pharmaceuticals) is a biopharmaceutical company focused on oncology therapies.
View companyABL Bio
HQ
Employees
55
ABL Bio is a biotech research company focusing on the development of therapeutic drugs for immuno-oncology and neurodegenerative disease.
View companyNiKang Therapeutics
HQ
Wilmington, US
Employees
45↓ 2% decrease
NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.
View company